These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3126744)

  • 1. Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes.
    Bowlin TL; Sunkara PS
    Biochem Biophys Res Commun; 1988 Mar; 151(2):859-64. PubMed ID: 3126744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granular lymphocytes.
    Yagita M; Saksela E
    Scand J Immunol; 1990 Mar; 31(3):275-82. PubMed ID: 2108487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swainsonine, an inhibitor of mannosidase II during glycoprotein processing, enhances concanavalin A-induced T cell proliferation and interleukin 2 receptor expression exclusively via the T cell receptor complex.
    Bowlin TL; Schroeder KK; Fanger BO
    Cell Immunol; 1991 Oct; 137(1):111-7. PubMed ID: 1832085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of swainsonine on interleukin-2 alpha chain receptor expression and proliferation of human lymphocytes.
    Myc A; DeAngelis P; Lassota P; Melamed MR; Darzynkiewicz Z
    Clin Exp Immunol; 1991 Jun; 84(3):406-10. PubMed ID: 1904326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing.
    Bowlin TL; McKown BJ; Kang MS; Sunkara PS
    Cancer Res; 1989 Aug; 49(15):4109-13. PubMed ID: 2501020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2.
    Wall KA; Pierce JD; Elbein AD
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5644-8. PubMed ID: 3135550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAb.
    van Kemenade FJ; Rotteveel FT; van den Broek LA; Baars PA; van Lier RA; Miedema F
    J Leukoc Biol; 1994 Aug; 56(2):159-65. PubMed ID: 7915296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhibitors of glycoprotein processing on cytokine secretion and production in anti CD3-stimulated T cells.
    Kosuge T; Tamura T; Nariuchi H; Toyoshima S
    Biol Pharm Bull; 2000 Jan; 23(1):1-5. PubMed ID: 10706401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic resistance to glycoprotein processing inhibitors in Chinese hamster ovary cells. The role of a novel mutation in the asparagine-linked glycosylation pathway.
    Lehrman MA; Zeng Y
    J Biol Chem; 1989 Jan; 264(3):1584-93. PubMed ID: 2521484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors.
    Montefiori DC; Robinson WE; Mitchell WM
    Antiviral Res; 1989 Apr; 11(3):137-46. PubMed ID: 2472115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Hoke GM; Sarngadharan MG
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isomers of swainsonine on glycosidase activity and glycoprotein processing.
    Elbein AD; Szumilo T; Sanford BA; Sharpless KB; Adams C
    Biochemistry; 1987 May; 26(9):2502-10. PubMed ID: 3111529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mannosidase inhibitors 1-deoxymannojirimycin and swainsonine have no effect on the biosynthesis and infectivity of Rous sarcoma virus.
    Bosch JV; Tlusty A; McDowell W; Legler G; Schwarz RT
    Virology; 1985 May; 143(1):342-6. PubMed ID: 2998010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glycoprotein-processing inhibitors on the secretion of glycoproteins by Madin-Darby canine kidney cells.
    Pan YT; Hori H; Elbein AD
    Biochem Cell Biol; 1987 Apr; 65(4):345-53. PubMed ID: 2955798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing.
    Sunkara PS; Bowlin TL; Liu PS; Sjoerdsma A
    Biochem Biophys Res Commun; 1987 Oct; 148(1):206-10. PubMed ID: 2960321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II.
    Tulsiani DR; Harris TM; Touster O
    J Biol Chem; 1982 Jul; 257(14):7936-9. PubMed ID: 6806288
    [No Abstract]   [Full Text] [Related]  

  • 17. Swainsonine induces the production of hybrid glycoproteins and accumulation of oligosaccharides in male reproductive tissues of the rat.
    Tulsiani DR; Skudlarek MD; Orgebin-Crist MC
    Biol Reprod; 1990 Jul; 43(1):130-8. PubMed ID: 2118392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swainsonine and castanospermine blockade of mannose glycoprotein uptake by macrophages. Apparent inhibition of receptor-mediated endocytosis by endogenous ligands.
    Chung KN; Shepherd VL; Stahl PD
    J Biol Chem; 1984 Dec; 259(23):14637-41. PubMed ID: 6438101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of DNA synthesis in murine lymphocytes by the drug swainsonine: immunomodulatory properties.
    White SL; Schweitzer K; Humphries MJ; Olden K
    Biochem Biophys Res Commun; 1988 Jan; 150(2):615-25. PubMed ID: 3124836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of swainsonine. Inhibition of human alpha-mannosidases by swainsonine analogues.
    Cenci di Bello I; Fleet G; Namgoong SK; Tadano K; Winchester B
    Biochem J; 1989 May; 259(3):855-61. PubMed ID: 2499316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.